What Is Trichophyton Indotineae, and Why Are Doctors Talking About It?
Trichophyton indotineae is a newly recognized skin fungus that frequently resists terbinafine, one of the most widely prescribed oral antifungal medications. Until recently, it was misclassified under a close relative, Trichophyton mentagrophytes, which is why it went unnoticed for so long.
While it first drew widespread attention in India, the CDC now reports cases across Europe, North America, South America, and Africa. In the United States, the first wave of cases was documented in a 2023 CDC report covering New York City.
To keep this in perspective: T. indotineae mostly shows up on body skin (like the groin or torso) rather than toenails. Most toenail infections still stem from familiar fungi like Trichophyton rubrum (covered in our guide to what causes toenail fungus). However, this emerging species matters deeply if your skin or nails have stopped responding to treatments that should have worked.
Can Trichophyton Indotineae Cause Toenail Fungus?
Yes, but it is uncommon. A 2023 review in the Indian Journal of Dermatology notes that this fungus is primarily restricted to the trunk and groin, with nail and foot involvement reported less frequently.
Nail cases do occur, such as a 2025 Paris case report involving toenails, but data shows they are the exception. For instance, a 17-year review of over 34,000 samples in South East England found T. rubrum behind 80.5% of toenail infections, with zero T. indotineae cases identified.
| Feature | Usual Cause (T. rubrum) | T. indotineae |
|---|---|---|
| Where it usually appears | Toenails and feet | Groin, thighs, trunk, and face; nails less often |
| Share of toenail cases | About 80% in one large UK lab study | None found in that study |
| Terbinafine response | Often responds, though resistance is rising | Frequently resistant |
| Lab identification | Standard culture usually identifies it | Often requires DNA sequencing |
So, if you are fighting a stubborn toenail infection, the odds still favor the familiar culprit. However, resistance isn't limited to a single new species: the CDC notes rising terbinafine resistance in T. rubrum as well. That's why a nail that refuses to budge deserves a closer clinical look.
Why Do Some Fungi Resist Common Antifungal Medicines?
Small genetic mutations allow the fungus to bypass terbinafine. Normally, terbinafine works by blocking an enzyme called squalene epoxidase, which the fungus requires to build its protective outer membrane. According to a 2024 review of dermatophyte resistance, resistant strains carry specific gene mutations that make the enzyme less vulnerable to the drug.
A mutation doesn't mean every treatment is doomed, but it does mean terbinafine will struggle to clear the infection.
What Practices May Be Fueling Resistance?
The CDC highlights several common factors contributing to resistant ringworm and fungal infections:
- Overusing over-the-counter antifungal creams
- Applying steroid creams to undiagnosed fungal rashes
- Using antifungal medications when they aren't the right fit
- Stopping prescription courses prematurely
How Common Is Resistant Toenail Fungus in the United States?
Exact numbers are unknown, but early surveillance shows resistance markers are climbing rapidly. Because routine susceptibility testing isn't widely required or performed, true infection rates are difficult to track.
However, recent data sheds light on the trend:
-
U.S. Toenail Study: A 2024 study in Mycoses analyzed over 62,000 U.S. toenail samples. Dermatophytes appeared in 38.5% of samples (83.6% belonging to the T. rubrum group).
📊 Quick Stat: Terbinafine resistance gene mutations in that study more than doubled from 29.0 to 61.9 per 1,000 persons between early 2022 and mid-2023.
- New York Skin Data: A 2026 report in the Journal of Clinical Microbiology identified 135 T. indotineae cases across NYC and nearby counties from 2022 to 2024. Roughly 57% required higher concentrations of terbinafine to inhibit growth in the lab, and up to 52% showed reduced susceptibility to azole antifungals like itraconazole.
Important note: These studies track mutations and lab behavior, not individual patient outcomes. A mutation doesn't guarantee your specific infection won't clear, but it strongly signals that further investigation is warranted.
Who Is Most Vulnerable to Resistant Fungi?
Anyone can contract a resistant strain, but specific risk factors appear consistently in clinical research:
- Recent Travel: Travel to South Asia within the past three months, or close contact with someone who traveled there (American Academy of Dermatology). Note that cases with zero travel history are also documented.
- Advanced Age: In the U.S. toenail study, adults over 70 were more likely to harbor the T. mentagrophytes group, including resistance mutations.
- Previous Treatment Struggles: Past use of steroid creams on fungal rashes, or multiple rounds of ineffective antifungal treatments.
- Compromised Immunity: Heavy corticosteroid use or weakened immune systems. A 2024 expert review notes that fungi can spread widely across the skin in these groups. If this applies to you, check out our guide on nail fungus during chemo or after a transplant.
- Environmental Factors: Warm, humid, crowded living conditions or shared gear.
Keep in mind that most reported T. indotineae cases occur in individuals with fully healthy immune systems—so a lack of traditional risk factors does not rule it out.
Is It Treatment Resistance or Just Slow Nail Growth?
Toenails grow notoriously slowly, making it easy to mistake normal progress for treatment failure. Full nail turnover can take anywhere from 12 to 18 months, and the AAD does not set a strict time frame for when to declare an oral medication a failure.
Signs of Normal, Slow Growth
- Healthy, clear nail is visibly growing in from the cuticle base, even if the older, distal part remains discolored.
- No new skin rashes have developed.
- No other nails are showing changes.
Signs Worth Discussing With Your Doctor
- New nail growth at the base remains just as discolored, thick, or crumbly after the expected milestone time frame.
- The infection flares up immediately after completing a full, proper course of treatment.
- Additional nails begin changing.
- You develop itchy, red, scaly patches on the groin, thighs, buttocks, trunk, or face—particularly in a distinct "ring-within-a-ring" pattern described by the AAD.
- A rapidly spreading rash or a rash that changed appearance dramatically after applying a steroid cream (steroid-modified tinea).
Nuance check: Itching can linger long after a fungal skin infection has actually cleared, meaning a lab test is the only definitive way to confirm active infection. If your medicine genuinely stopped working, explore our guides on conditions often mistaken for fungus, why treatments stop working, and the expected clearance timeline.
How Is Trichophyton Indotineae Identified, and What Tests Should You Ask For?
Confirmation usually requires DNA sequencing, because standard lab cultures often misidentify the species as a close relative. The AAD notes that only specialized reference labs in the U.S. currently offer this capability, requiring your doctor to send out samples.
Advanced PCR testing, like the method used in the 2024 U.S. toenail study, can screen for specific terbinafine resistance mutations simultaneously. To learn the basics first, read our breakdown of KOH, culture, and PCR testing.
5 Essential Questions to Bring to Your Appointment
- Can we confirm a fungal infection with a lab test before I start or switch medications?
- Can my sample be sent for DNA identification or resistance screening, and what are the out-of-pocket costs?
- Should you examine my skin alongside my nails?
- Do my current medications, heart health history, or liver profile impact my treatment options?
- When should we schedule a follow-up, and how will we objectively measure whether the treatment is working?
What Do Doctors Prescribe When Terbinafine Fails?
Itraconazole is a common next-step oral option, though treatment courses are frequently extended. While fluconazole and griseofulvin are generally less effective, reviews indicate itraconazole may be prescribed for longer durations or higher doses when terbinafine fails.
However, it is not a foolproof solution; resistant strains showing reduced azole sensitivity have also been documented. For skin infections, AAD guidance suggests courses ranging from 6 to 8 weeks, or up to 20 weeks for severe cases, though relapses can still happen. Nail infections require significantly longer oversight.
Important Safety Warnings for Itraconazole
Because itraconazole is a powerful prescription medication, the FDA prescribing information carries severe boxed warnings:
- Heart Health: It must not be prescribed for nail fungal infections in patients with evidence of congestive heart failure or a history of heart muscle weakness.
- Drug Interactions: Many common prescription medications cannot be taken concurrently due to the risk of dangerous heart rhythm abnormalities.
- Liver Safety: Rare instances of serious liver injury have been reported, sometimes within the first week of starting therapy.
Be completely transparent with your doctor about every prescription drug, over-the-counter remedy, and herbal supplement you take. For deeper reading, review our guides on oral antifungal side effects, why blood tests are necessary, and terbinafine and antidepressant interactions.
How Can You Protect Yourself and Your Household?
Practicing rigorous hygiene keeps skin clean, dry, and resilient against all forms of foot and skin fungi:
- Never share towels, socks, shoes, or nail clippers.
- Launder clothing, towels, and bedding using high-heat settings, as recommended by the AAD.
- Sanitize hard surfaces like shower stalls and bathroom floors using a diluted bleach solution.
- Dry your feet thoroughly, especially between the toes, and wear shower shoes in public gyms, pools, and locker rooms.
- Air out and clean your footwear regularly, and read our guide on whether you really need to discard your old shoes.
- Monitor your skin alongside your nails, as fungi can easily spread across the body (see how toenail fungus actually spreads).
- Avoid applying steroid creams to any undiagnosed skin rash.
What Are the Biggest Myths About Resistant Nail Fungus?
Five ideas come up again and again, and the research does not support any of them as they are usually stated. Here is what the sources actually say.
Myth: If terbinafine failed, no medicine will work
Fact: Resistance mutations make terbinafine in particular less effective. A 2024 review of antifungal resistance notes that doctors commonly turn to itraconazole, a different oral antifungal, when terbinafine fails. It is not a guarantee, though. Some New York isolates also showed raised azole results in the lab, which is why test results should guide the choice.
Myth: This new resistant fungus is behind most toenail fungus
Fact: Most toenail fungus still comes from the familiar T. rubrum group. It accounted for 80.5% of toenail infections in a 17 year UK review and 83.6% of the dermatophytes found in a U.S. study of 62,056 toenail samples. T. indotineae mostly affects skin on the groin, thighs, trunk, and face.
Myth: Itching means the fungus is still there
Fact: Itching and dry skin can linger after a fungal skin infection has cleared. American Academy of Dermatology guidance advises a KOH lab test to confirm whether fungus remains when itching continues after treatment.
Myth: A resistance mutation means my nail will not get better
Fact: The U.S. toenail study reported how common resistance mutations were, not how individual patients responded. A mutation alone cannot predict how your nail will do. It is a reason to ask your doctor about testing, not a verdict.
Myth: Only people who have traveled to South Asia need to worry
Fact: Travel is a documented risk factor, but dermatology guidance notes that cases without any travel history have been documented. The U.S. toenail study also found resistance mutations in samples submitted from across the country.
Frequently Asked Questions About Trichophyton Indotineae
Is Trichophyton indotineae the same fungus that usually causes toenail fungus?
No. Most toenail fungus is caused by Trichophyton rubrum, whereas T. indotineae is a distinct, emerging species that predominantly affects body skin (such as the groin, trunk, and face). While nail cases do happen, they are much less common.
Does terbinafine still work for toenail fungus?
Yes, for many people it remains an effective first-line choice supported by the CDC. However, resistance mutations are on the rise. If your treatment fails to yield results, talk to your doctor about lab testing.
How can I tell if my nail fungus is resistant?
You cannot determine resistance visually. Slow nail growth, missed doses, or look-alike conditions can mimic a treatment failure. Specialized lab testing, including DNA sequencing and mutation screening, is required to find the true cause.
Is Trichophyton indotineae contagious?
Like other dermatophytes, it spreads through close physical contact and shared personal items. Avoid sharing towels or footwear, wash items on high heat, and consult a clinician if a rash spreads or resists initial care.
Should I stop taking my current medication if I suspect resistance?
No. Stopping an antifungal course prematurely can actively worsen drug resistance. Finish your prescribed regimen unless instructed otherwise by your physician, and contact them promptly if you notice side effects or zero progress.
Key Takeaways
- Emerging Species: T. indotineae is a newly identified fungus that frequently resists terbinafine and primarily affects body skin rather than nails.
- Toenails Still Favor Rubrum: While nail cases exist, the vast majority of toenail infections continue to be caused by T. rubrum.
- Rising Resistance: U.S. data reveals that terbinafine resistance gene mutations in toenail samples more than doubled between early 2022 and mid-2023.
- Advanced Testing Is Key: Standard clinical labs can mistake T. indotineae for related species, meaning DNA-based testing or specialized PCR screening is often necessary.
- Tests Beat Guessing: Because slow nail growth looks identical to treatment failure, lab confirmation is far safer than trial and error.
- Alternative Options Exist: Itraconazole is a common next step when terbinafine fails, but it carries strict heart, liver, and drug-interaction warnings that require careful medical oversight.
- Hygiene Matters: High-heat laundering, avoiding shared gear, and protecting skin health are your best defenses against spreading resistant strains.
Comments